Hatzimichael, E.; Timotheatou, D.; Koumpis, E.; Benetatos, L.; Makis, A.
Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis. Diseases 2022, 10, 85.
https://doi.org/10.3390/diseases10040085
AMA Style
Hatzimichael E, Timotheatou D, Koumpis E, Benetatos L, Makis A.
Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis. Diseases. 2022; 10(4):85.
https://doi.org/10.3390/diseases10040085
Chicago/Turabian Style
Hatzimichael, Eleftheria, Despoina Timotheatou, Epameinondas Koumpis, Leonidas Benetatos, and Alexandros Makis.
2022. "Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis" Diseases 10, no. 4: 85.
https://doi.org/10.3390/diseases10040085
APA Style
Hatzimichael, E., Timotheatou, D., Koumpis, E., Benetatos, L., & Makis, A.
(2022). Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis. Diseases, 10(4), 85.
https://doi.org/10.3390/diseases10040085